The re-expression of SLIT2, MAL and IGFBP7 that was observed in lung cancer cell lines after treatment with a demethylating agent exhibited good concordance with the methylation status, suggesting that expression of those genes was downregulated mainly by hypermethylation. This evidence concerns the gene IGFBP7 and lung carcinoma.